Different Reversal Agents in Pediatric Day-case Cancer Surgery
NCT03996655
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Post-operative Residual Curarization
Interventions
DRUG:
Sugammadex Injection [Bridion]
DRUG:
Neostigmine
Sponsor
National Cancer Institute, Egypt